We are pleased to announce the publication of new guidance for laboratories that are providing human papillomavirus (HPV) testing and cervical cytology services for the NHS Cervical Screening Programme. Please note that an incorrect version of the new guidance for …
The NHS Cervical Screening Programme is pleased to announce the launch of new invitation and result letters, along with new information leaflets.
Explanation to accompany a new cervical screening HPV primary report.
This week is Cervical Screening Awareness Week (CSAW) and Jo’s Cervical Cancer Trust chief exec Rob Music has written a guest blog for us talking about cell changes.
This is the second in a series of blogs we're running by Rob Music, chief executive of Jo’s Cervical Cancer Trust. The focus of this one is on raising awareness of human papillomavirus (HPV) with the upcoming roll-out of HPV primary screening.
In 2013, 6 labs in England began looking for HPV first to see if this new test could be used in the cervical screening programme. The results from this pilot have now been published in the British Medical Journal (BMJ).
We have launched new training resources to meet requirements set out in guidance for cervical screening providers on implementing high-risk (hr) HPV testing.
A positive HPV test result has the potential to cause anxiety. This blog is about research taking place into how women feel about receiving such a result.
We have published new guidance for local cervical screening providers on implementing high-risk human papillomavirus (hrHPV) testing as the programme’s primary screening test.
A blog by Rob Music, chief executive of Jo’s Cervical Cancer Trust, as part of Cervical Cancer Prevention Week (21 to 27 January 2019).
GOV.UK